Table 2 Summary of published cases of M. wolinskyi bacteremia
Age | Gender | Comorbidities | Type of infection | Treatment | Intravascular devices | Device removal | Gram stain | Outcome | Time to positive blood culture (days) | |
|---|---|---|---|---|---|---|---|---|---|---|
Chen et al. [2] | 22 | f | NHL on chemotherapy | BSI/septic arthritis in native joint | Surgical debridement + AMK (1 month), MXF and MIN (6 months) | Venous port | Yes | N/A | N/A | 3 |
Ohno et al. [3] | 55 | f | CML on chemotherapy | BSI No source identified | AMK (1 month), MIN and LVX (6 months) | None | N/A | GPR | Good outcome at 1.5-year follow-up | 5 |
Ariza-Heredia et al. [4] | 16 | m | Congenital aortic stenosis status post-Ross procedure | BSI, likely endocarditis and infected aortic root graft | AMK, MXF and DOXY (ongoing) | Vascular graft | Yes | N/A | Underwent pulmonary artery conduit replacement | 5 |
Kitajima et al. [5] | 82 | m | Status-post AVR and MVR | Prosthetic valve endocarditis | AMK, IPM and CLR (6 weeks) then CIP and MIN (total 12 months) | Prosthetic valve | No | GPR | Cure | 5 |
Present case | 43 | f | AML post hematopoietic stem cell transplantation | Catheter related blood stream infection | AMK, IPM/CS, LVX and AZM (6 days) AMK, IPM/CS, LVX and MIN (13 days), AMK, MXF and MIN (15 days) then MXF (4 months) and MIN (6 months) | PICC | Yes | GPR | Cure | 2 |